City State Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9K Hold
160
0.01% 334
2026
Q1
$46.8K Hold
160
0.01% 364
2025
Q4
$56.1K Hold
160
0.02% 331
2025
Q3
$51.7K Hold
160
0.01% 340
2025
Q2
$62.2K Hold
160
0.02% 313
2025
Q1
$69.6K Hold
160
0.02% 301
2024
Q4
$59K Sell
160
-5
-3% -$2.09K 0.02% 304
2024
Q3
$85.8K Hold
165
0.03% 273
2024
Q2
$89.4K Buy
165
+20
+14% +$10.6K 0.04% 258
2024
Q1
$75K Buy
145
+23
+19% +$11.4K 0.03% 271
2023
Q4
$58K Hold
122
0.03% 282
2023
Q3
$53K Hold
122
0.03% 286
2023
Q2
$54K Hold
122
0.03% 284
2023
Q1
$56K Hold
122
0.03% 272
2022
Q4
$63K Hold
122
0.04% 254
2022
Q3
$55K Hold
122
0.04% 253
2022
Q2
$59K Hold
122
0.04% 251
2022
Q1
$60K Hold
122
0.04% 264
2021
Q4
$57K Buy
+122
New +$51.3K 0.04% 281

Other funds holding ELV

City State Bank's ELV Position: Q2 2026 in Review

City State Bank held its Elevance Health (ELV) position steady in Q2 2026 at 160 shares worth $61.9K. The position accounts for 0.01% of the portfolio, ranked #334.

City State Bank first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $89.4K in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • City State Bank held 160 shares of Elevance Health worth $61.9K as of Q2 2026.
  • City State Bank left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of City State Bank's portfolio in Q2 2026, its #334 holding.
  • City State Bank first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's Elevance Health position peaked at $89.4K in Q2 2024.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.